Loomis, Sayles & Company’s Progyny PGNY Stock Holding History

Loomis, Sayles & Company’s Portfolio PGNY Stock Details PGNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.8M	Buy	988,390 +212,810	+27%	+$4.56M	0.02%	264
2025 Q4	$19.9M	Buy	+775,580	New	+$17.8M	0.02%	235
2024 Q3	–	Sell	-901,974	Closed	-$25.8M	–	735
2024 Q2	$25.8M	Sell	901,974 -246,370	-21%	-$7.42M	0.04%	214
2024 Q1	$43.8M	Buy	1,148,344 +53,796	+5%	+$2.03M	0.06%	144
2023 Q4	$40.7M	Buy	1,094,548 +84,270	+8%	+$2.83M	0.06%	146
2023 Q3	$34.4M	Buy	1,010,278 +63,136	+7%	+$2.38M	0.06%	158
2023 Q2	$37.3M	Buy	+947,142	New	+$34.2M	0.06%	152

Other funds holding PGNY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Loomis, Sayles & Company's PGNY Position: Q1 2026 in Review

Loomis, Sayles & Company increased its Progyny (PGNY) stake by 27% in Q1 2026, buying an estimated $4.56M and bringing the position to 988,390 shares worth $16.8M. The position accounts for 0.02% of the portfolio, ranked #264.

Loomis, Sayles & Company first reported a position in PGNY in Q2 2023 and has held it in 7 quarters since. The position peaked at $43.8M in Q1 2024. 292 funds tracked by Wall St. Rank hold PGNY as of Q1 2026.

Loomis, Sayles & Company held 988,390 shares of Progyny worth $16.8M as of Q1 2026.
Loomis, Sayles & Company bought 212,810 Progyny shares in Q1 2026, an estimated $4.56M.
Progyny made up 0.02% of Loomis, Sayles & Company's portfolio in Q1 2026, its #264 holding.
Loomis, Sayles & Company first reported a position in Progyny in Q2 2023 and has held it in 7 quarters since.
Loomis, Sayles & Company's Progyny position peaked at $43.8M in Q1 2024.
292 funds tracked by Wall St. Rank held Progyny as of Q1 2026.

Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.